Article Figures & Data
Figures
- Figure 1.
Overall survival of patients with esophageal cancer in the high-lymphocyte-monocyte ratio (LMR) (≥1.7) and low-LMR (<1.7) groups.
- Figure 2.
Recurrence-free survival of patients with esophageal cancer in the high-lymphocyte-monocyte ratio (LMR) (≥1.7) and low-LMR (<1.7) groups.
Tables
In this issue
Jump to section
Related Articles
Cited By...
- The Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score as an Independent Prognostic Factor for Esophageal Cancer Patients who Received Curative Treatment
- The Clinical Impact of the Prognostic Immune and Nutritional Index in Gastric Cancer Patients Who Received Curative Treatment
- The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal Cancer Patients Who Receive Curative Treatment
- The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment